Equine fFN antibody and antigen (recombinant protein)

Diagnostic anti-Equine fFN antibodies pairs and antigen for animal health (animal Equine/Horse premature delivery) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-EQU-fFN-Ag01 Recombinant Equine fFN protein 3090
GMP-EQU-fFN-Ab01 Anti-Equine fFN mouse monoclonal antibody (mAb) 1953
GMP-EQU-fFN-Ab02 Anti-Equine fFN mouse monoclonal antibody (mAb) 1953
GMP-EQU-fFN-Ab03 Anti-Equine fFN human monoclonal antibody (mAb) 1953
GMP-EQU-fFN-Ab04 Anti-Equine fFN human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-EQU-fFN-Ag01
Product Name Recombinant Equine fFN protein
Target/Biomarker Equine Fetal fibronectin (fFN)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Equine Fetal fibronectin antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in fFN level test of animal Equine/Horse with premature delivery.
Tag His
Products description Recombinant Equine fFN protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-fFN-Ab01, GMP-EQU-fFN-Ab02
Product Name Anti-Equine fFN mouse monoclonal antibody (mAb)
Target/Biomarker Equine Fetal fibronectin (fFN)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Equine Fetal fibronectin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-fFN antibodies in fFN level test of animal Equine/Horse with premature delivery.
Tag mFc
Products description Anti-Equine fFN mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-fFN antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-fFN-Ab03, GMP-EQU-fFN-Ab04
Product Name Anti-Equine fFN human monoclonal antibody (mAb)
Target/Biomarker Equine Fetal fibronectin (fFN)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Equine Fetal fibronectin antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-fFN antibodies in fFN level test of animal Equine/Horse with premature delivery.
Tag hFc
Products description Anti-Equine fFN human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-fFN antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Equine Fetal Fibronectin (e-fFN) stands as an indispensable sentinel in the realm of equine reproductive biology. This glycoprotein, uniquely situated within the amniotic fluid and placental tissues of pregnant horses, orchestrates the symphony of equine pregnancy. Structurally, e-fFN is part of the fibronectin family, a group of adhesive proteins renowned for their roles in cell adhesion and tissue organization. At its core, e-fFN serves as a molecular adhesive. During pregnancy, it acts as the adhesive that firmly binds developing equine fetuses to the uterine wall. This adhesion is not merely structural; it is the linchpin that ensures the stability of the maternal-fetal connection. Without the steadfast grip provided by e-fFN, developing foals could be at risk of detachment from the uterine lining, potentially leading to a cascade of complications. Beyond its adhesive prowess, e-fFN takes on an additional role in immune regulation. Pregnancy in horses presents a unique challenge for the maternal immune system. It must tolerate the presence of semi-allogeneic fetuses—offspring that share some, but not all, genetic material with the mother. e-fFN actively contributes to immune tolerance, ensuring that the mare's immune system does not launch a hostile response against the developing foal. This immunomodulatory function is pivotal for the success of equine pregnancies.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment